ETF Holdings Breakdown of LEGN
Stock Name | Legend Biotech Corp |
Ticker | LEGN(USD) NASDAQ |
TYPE | Common Stock |
Country | USA |
ISIN | US52490G1022 |
LEI | 254900EIUFZTW136H859 |
News associated with LEGN
- Zurcher Kantonalbank Zurich Cantonalbank Trims Position in Legend Biotech Co. (NASDAQ:LEGN)
- Zurcher Kantonalbank Zurich Cantonalbank decreased its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 18.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 40,913 shares of the company’s stock after selling 9,355 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Legend […] - 2025-03-19 07:40:51
- Morgan Stanley Issues Pessimistic Forecast for Legend Biotech (NASDAQ:LEGN) Stock Price
- Legend Biotech (NASDAQ:LEGN – Get Free Report) had its target price dropped by analysts at Morgan Stanley from $82.00 to $80.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s target price points to a potential upside of 111.19% from the company’s current […] - 2025-03-19 06:28:56
- Daiwa Securities Group Inc. Raises Stock Position in Legend Biotech Co. (NASDAQ:LEGN)
- Daiwa Securities Group Inc. lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 165.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 8,516 shares of the company’s stock after acquiring an additional 5,309 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Legend Biotech were worth $278,000 as […] - 2025-03-17 08:06:55
- Company News for Mar 12, 2025
- Companies in The News Are: FRG, ORCL, LEGN, PAY - 2025-03-12 13:20:00
- Legend Biotech Co. (NASDAQ:LEGN) Receives $79.50 Average PT from Brokerages
- Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) have been given a consensus rating of “Buy” by the twelve research firms that are covering the stock, MarketBeat Ratings reports. Twelve analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the stock […] - 2025-03-03 06:50:55
- Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by Sumitomo Mitsui Trust Group Inc.
- Sumitomo Mitsui Trust Group Inc. lowered its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 2.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 173,766 shares of the company’s stock after selling 3,461 shares during the quarter. Sumitomo Mitsui Trust […] - 2025-02-14 09:35:09
- Contrasting Legend Biotech (NASDAQ:LEGN) and COMPASS Pathways (NASDAQ:CMPS)
- COMPASS Pathways (NASDAQ:CMPS – Get Free Report) and Legend Biotech (NASDAQ:LEGN – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Earnings & Valuation This table compares COMPASS Pathways […] - 2025-02-06 06:06:58
LEGN institutional holdings
The following institutional investment holdings of LEGN have been identified Date | ETF ISIN/Name | Num Shares | Book value |
Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119
Stack trace:
#0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query()
#1 {main}
thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119